Efficacy of a Dietary Supplement on Parameters of Skin Aging in Men and Women

October 11, 2023 updated by: Natals, Inc. dba Ritual

Evaluating the Efficacy of a Dietary Supplement on Parameters of Skin Aging: a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

As the body ages, the skin experiences natural changes in structure and composition. These changes may manifest visibly as increased skin dryness, wrinkling, and a loss of firmness/elasticity. In this double-blind, randomized, placebo-controlled trial, the investigators will recruit healthy men and women with mild to moderate signs of skin aging and randomly assign them to either receive a HyaCera™ or placebo for 12 weeks. The investigators will perform a series of objective and subjective measurements to assess changes in skin condition. The investigators hypothesize that consumption of HyaCera™ leads to improvements in the general condition of the skin including skin hydration, crow's feet wrinkling, and other skin aging parameters.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Jersey
      • Raritan, New Jersey, United States, 08869
        • Princeton Consumer Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy male and female volunteers, 25 - 70 years old with mild to moderate fine lines and wrinkles
  • All ethnicities and skin types
  • Willing to maintain current skincare regimen on face, arms, and legs and withhold all facial and body treatments throughout the course of the study

Exclusion Criteria:

  • Self-reported pregnant or breastfeeding or planning to become pregnant during the course of the study
  • Any conditions on the face, arms and legs that would interfere with evaluations
  • Under treatment for any known health issues/medical conditions including chronic health conditions and skin diseases/conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active
Participants receive 1 HyaCera™ capsule orally once daily for 12 weeks
1 Ritual HyaCera capsule once daily
Placebo Comparator: Placebo
Participants receive 1 placebo capsule orally once daily for 12 weeks
1 placebo capsule once daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Crow's Feet Wrinkles
Time Frame: at week 0, Week 4, Week 8, and Week 12
Degree of crow's feet wrinkling will be measured via Visioscan®
at week 0, Week 4, Week 8, and Week 12
Skin Smoothness
Time Frame: at week 0, Week 4, Week 8, and Week 12
Skin smoothness will be measured via Visioscan®
at week 0, Week 4, Week 8, and Week 12
Skin Hydration
Time Frame: at week 0, Week 4, Week 8, and Week 12
Skin surface hydration will be measured via Corneometer® 825
at week 0, Week 4, Week 8, and Week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin Elasticity
Time Frame: at week 0, Week 4, Week 8, and Week 12
Skin elasticity will be measured via Cutometer® MPA 580
at week 0, Week 4, Week 8, and Week 12
Skin Barrier Function
Time Frame: at week 0, Week 4, Week 8, and Week 12
Skin barrier function (as transepidermal water loss) will be measured via Tewameter®
at week 0, Week 4, Week 8, and Week 12
Skin Scaliness
Time Frame: at week 0, Week 4, Week 8, and Week 12
Skin scaliness will be measured via Visioscan®
at week 0, Week 4, Week 8, and Week 12

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dermatologist grading of skin condition
Time Frame: at week 0, Week 4, Week 8, and Week 12
Visual and tactile dermatologist evaluation of skin condition (fine lines in the crow's feet area, wrinkles in the crow's feet area, skin dryness, skin radiance, and skin smoothness) based on 10-point grading scale (with 0 being no signs of aging and 9 being the most severe)
at week 0, Week 4, Week 8, and Week 12
Self-evaluation of perceived changes in skin condition
Time Frame: at week 0, Week 4, Week 8, and Week 12
Self-evaluation of changes in skin condition and signs of skin aging (i.e. fine lines & wrinkles, skin texture, skin smoothness, skin plumpness, skin glow/radiance, skin hydration, skin elasticity, skin redness, skin itchiness) using a 5-point Likert scale (options: much worse, somewhat worse, stayed the same, somewhat better, much better)
at week 0, Week 4, Week 8, and Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2023

Primary Completion (Actual)

October 6, 2023

Study Completion (Actual)

October 6, 2023

Study Registration Dates

First Submitted

August 16, 2023

First Submitted That Met QC Criteria

October 11, 2023

First Posted (Actual)

October 16, 2023

Study Record Updates

Last Update Posted (Actual)

October 16, 2023

Last Update Submitted That Met QC Criteria

October 11, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Aging

Clinical Trials on HyaCera™

3
Subscribe